Clinical trials: Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Hemodynamics, Cytoreductive Surgery
HIPEC Surgery and Hemodynamics
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) involves the intraoperative administration of heated chemotherapeutic agents into the abdominal cavity following cytoreductive surgery (CRS).
- Conditions
- Hemodynamics, Cytoreductive Surgery, Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
- Trial name
- NCT06922227
- Where
- Turkey (Türkiye)
- Volunteers
- 15 people
- Sponsor
- Miray Gözde Özdemir
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Noradrenaline Infusion Versus Phenylephrine Infusion in Improving Serum Lactate Level in HIPEC
ABG PARAMETERS ARE CHANGED DURING HIPEC, WE TRIED TO FIND COMPARISON BETWEEN NORADRENALINE AND PHENYLEPHRINE IN OPTIMIZING ABG PARAMETERS THAT REFLECTS ORGAN PERFUSIONS ESPECIALLY SERUM LACTATE
- Trial name
- NCT04144465
- Testing
- NORADRENALIN, PHENYLEPHRINE
- Where
- Egypt
- Volunteers
- 30 people
- Sponsor
- Suez Canal University
Ovarian Cancer, Epithelial Ovarian Cancer
A Randomized Prospective Trail of HIPEC in Recurrent Ovarian Cancer Patients With HRR Mutation
A phase III prospective study with the primary objective to investigate the benefit of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in ovarian cancer patients with mutations in homologous recombination repair (HRR) genes.
- Conditions
- Ovarian Cancer, Epithelial Ovarian Cancer, Ovarian Cancer, Epithelial, Hyperthermic Intraperitoneal Chemotherapy(HIPEC)
- Trial name
- NCT04473339
- Testing
- CRS+HIPEC, CRS alone
- Where
- China
- Volunteers
- 280 people
- Sponsor
- CAI Hongbing
Ovarian Cancer, Ovary Neoplasm
Cytoreductive Surgery(CRS) Plus Hyperthermic Intraperitoneal Chemotherapy(HIPEC) With Lobaplatin in Advanced and Recurrent Epithelial Ovarian Cancer
A phase III prospective study with the primary objective to compare the efficacy and safety of HIPEC( Hyperthermic Intraperitoneal Chemotherapy).
- Conditions
- Ovarian Cancer, Ovary Neoplasm, Ovarian Neoplasms, Epithelial Ovarian Cancer
- Trial name
- HIPECOV (NCT03371693)
- Testing
- HIPEC, CRS, IVCT
- Where
- China
- Volunteers
- 112 people
- Sponsor
- Zhongnan Hospital